Interferon-beta for anti-virus therapy for respiratory diseases

Details Interferon-beta for anti-virus therapy for respiratory diseases Interferon-beta for anti-virus therapy for respiratory diseases

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 9/12 (2006.01) A61K 31/57 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2558212

The present invention provides the use of IFN-.beta., an agent that increases the expression of IFN-.beta., or a polynucleotide which is capable of expressing IFN-.beta. or said agent for the manufacture of a medicament for the treatment of rhinovirus-induced exacerbation of a respiratory disease selected from asthma and chronic obstructive pulmonary disease, wherein said treatment is by airway delivery of said medicament, e.g. by use of an aerosol nebuliser.

L'invention concerne l'utilisation de IFN-.beta., d'un agent qui augmente l'expression de IFN-.beta., ou d'un polynucléotide capable d'exprimer IFN-.beta. ou dudit agent pour la fabrication d'un médicament destiné au traitement de l'exacerbation induite par le rhinovirus d'une maladie respiratoire choisie parmi l'asthme et la bronchopneumopathie chronique obstructive, ledit traitement s'opérant par administration dudit médicament par voie aérienne, par exemple par l'utilisation d'un nébuliseur aérosol.

Affiliated with

Also associated with

Rating

Interferon-beta for anti-virus therapy for respiratory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon-beta for anti-virus therapy for respiratory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon-beta for anti-virus therapy for respiratory diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1372126